Search research articles
Contact Us
Filters
Showing results (21-30 of 706) with videos related to
Page
of 71
Sort By:
Postgraduate Medical Journal
|
November 4, 2011
Republished review: Triglycerides and atherogenic dyslipidaemia: extending treatment beyond statins in the high-risk cardiovascular patient
Gerald F Watts, Fredrik Karpe
Arteriosclerosis, Thrombosis, and Vascular Biology
|
April 3, 2004
Regulation of endothelial nitric oxide synthase by PPAR agonists: molecular and clinical perspectives
Gerald F Watts, Bart Staels
Current Opinion in Lipidology
|
May 2, 2017
Mode of action of berberine on lipid metabolism: a new-old phytochemical with clinical applications?
Amirhossein Sahebkar, Gerald F Watts
Expert Review of Cardiovascular Therapy
|
September 1, 2011
Why, when and how should hypertriglyceridemia be treated in the high-risk cardiovascular patient?
Gerald F Watts, Fredrik Karpe
Clinical Therapeutics
|
August 13, 2013
New LDL-cholesterol lowering therapies: pharmacology, clinical trials, and relevance to acute coronary syndromes
Amirhossein Sahebkar, Gerald F Watts
The Lancet. Public Health
|
May 6, 2019
A window into the heart of familial hypercholesterolaemia in the community
Gerald F Watts, Jing Pang
Current Opinion in Endocrinology, Diabetes, and Obesity
|
January 4, 2023
Xenosterolemia in clinical practice: what is in a name?
Wann Jia Loh, Gerald F Watts
Current Opinion in Lipidology
|
January 15, 2011
Recent advances in understanding the role and use of marine ω3 polyunsaturated fatty acids in cardiovascular protection
Gerald F Watts, Trevor A Mori
Clinical Chemistry
|
January 20, 2011
Whither the lipid profile: feast, famine, or no free lunch?
Gerald F Watts, Jeffrey S Cohn
Atherosclerosis. Supplements
|
May 11, 2010
Mechanisms for therapeutic correction of dyslipidaemia in insulin resistance and diabetes
Gerald F Watts, Dick C Chan
Page
of 71
Search research articles
Search
Showing results (21-30 of 706) with videos related to
Sort By:
Page
of 71
Postgraduate Medical Journal
|
November 4, 2011
Republished review: Triglycerides and atherogenic dyslipidaemia: extending treatment beyond statins in the high-risk cardiovascular patient
Gerald F Watts, Fredrik Karpe
Arteriosclerosis, Thrombosis, and Vascular Biology
|
April 3, 2004
Regulation of endothelial nitric oxide synthase by PPAR agonists: molecular and clinical perspectives
Gerald F Watts, Bart Staels
Current Opinion in Lipidology
|
May 2, 2017
Mode of action of berberine on lipid metabolism: a new-old phytochemical with clinical applications?
Amirhossein Sahebkar, Gerald F Watts
Expert Review of Cardiovascular Therapy
|
September 1, 2011
Why, when and how should hypertriglyceridemia be treated in the high-risk cardiovascular patient?
Gerald F Watts, Fredrik Karpe
Clinical Therapeutics
|
August 13, 2013
New LDL-cholesterol lowering therapies: pharmacology, clinical trials, and relevance to acute coronary syndromes
Amirhossein Sahebkar, Gerald F Watts
The Lancet. Public Health
|
May 6, 2019
A window into the heart of familial hypercholesterolaemia in the community
Gerald F Watts, Jing Pang
Current Opinion in Endocrinology, Diabetes, and Obesity
|
January 4, 2023
Xenosterolemia in clinical practice: what is in a name?
Wann Jia Loh, Gerald F Watts
Current Opinion in Lipidology
|
January 15, 2011
Recent advances in understanding the role and use of marine ω3 polyunsaturated fatty acids in cardiovascular protection
Gerald F Watts, Trevor A Mori
Clinical Chemistry
|
January 20, 2011
Whither the lipid profile: feast, famine, or no free lunch?
Gerald F Watts, Jeffrey S Cohn
Atherosclerosis. Supplements
|
May 11, 2010
Mechanisms for therapeutic correction of dyslipidaemia in insulin resistance and diabetes
Gerald F Watts, Dick C Chan
Page
of 71